Abstract:Background: Maternal depression is considered a major contributor to morbidity and mortality in pregnancy. A population at risk are U.S. born or immigrant Hispanic women, and few prenatal depression or immune studies have focused on this population. Objective: The research questions for the study were 1) What are the occurrences, risk factors and outcomes associated with depression in Hispanic pregnant women in the United States and 2) What are the associations of plasma immune cytokines and prenatal depression in this population. Study design: Women of self-reported Hispanic ethnicity were born in the continental United States or foreign-born. Screening of potential participants (n = 690) at a first prenatal clinic visit consisted of antibody testing for Toxoplasma gondii antibodies in a larger grant, and only the women with antibody levels below the cutoff for T. gondii positivity (N = 536) were included in the present study. All participants completed a health and demographic questionnaire, the Edinburgh Postpartum Depression (EPDS) scale, the Perceived Stress Scale (PSS), and the Medical Outcomes Study Social Support (MOS) scale. We surveyed electronic health records (EHR) for risk factors and adverse pregnancy outcomes in the sample. We further measured physical and mental health and seven plasma immune cytokines at four study visits during pregnancy in a longitudinal subsample (N = 128). Results: The frequency of EPDS scores of 10 (depression risk) or above was 18.6 % at the time of enrollment. Socioeconomic factors such as less education, greater unemployment, and U.S. born nativity were associated with greater depression risk, but these relationships became insignificant when we corrected for false discovery rate. Depression scores were not associated with adverse birth and pregnancy outcomes. The inflammatory cytokine TNF-α was significantly higher across pregnancy in women with depression risk (p < 0.03). Other inflammatory cytokines were higher in depressed women, but only at one time point in mid-pregnancy. Conclusions: Prenatal depression occurs in early pregnancy and then declines in Hispanic women. The frequency of depression and stress were higher in U.S. born compared to immigrant Hispanic women. There was an elevation in plasma levels of TNF-α through the pregnancy in depressed women, and elevations in other cytokines, at midpregnancy. The adverse pregnancy outcomes, including preterm delivery, known to be associated with prenatal depression were not present in this cohort.

Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy

Depressive and Anxiety Symptoms in the Early Puerperium Are Related to Increased Degradation of Tryptophan into Kynurenine, a Phenomenon Which is Related to Immune Activation

Using inflammatory biomarkers in early pregnancy to predict subsequent antenatal depression

The Cytokine, Chemokine, and Growth Factor Network of Prenatal Depression

Dysregulated placental expression of kynurenine pathway enzymes is associated with inflammation and depression in pregnancy

Inflammatory cytokines and prenatal depression: Is there a mediating role of maternal gut microbiota?

The Intersection between Tryptophan-Kynurenine Pathway Metabolites and Immune Inflammation, Hormones, and Gut Microbiota in Perinatal Depression

Association Between Gut Microbiota and Its Functional Metabolites with Prenatal Depression in Women

Body Image Dissatisfaction in Pregnant and Non-Pregnant Females is Strongly Predicted by Immune Activation and Mucosa-Derived Activation of the Tryptophan Catabolite (TRYCAT) Pathway

Effects of Pregnancy and Delivery on the Availability of Plasma Tryptophan to the Brain: Relationships to Delivery-Induced Immune Activation and Early Post-Partum Anxiety and Depression.

Depression in pregnant Hispanic women: Risk factors, pregnancy outcomes and plasma cytokines

IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome

Maternal negative affect in pregnancy predicts cytokine levels which in turn predict birth outcomes - A prospective longitudinal study in a low-risk population

Affective Symptoms in Pregnancy are Associated with the Vaginal Microbiome

Clinical correlation and prognostic value of xanthine and inflammatory factors in postpartum depression

Associations between Physiological Biomarkers and Psychosocial Measures of Pregnancy-Specific Anxiety and Depression with Support Intervention

Relationship between inflammatory biomarkers, vitamin D levels, and depressive symptoms in late pregnancy and during the postpartum period: a prospective, observational study

Inflammatory markers in pregnancy – surprisingly stable. Mapping trajectories and drivers in four large cohorts.

Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression

Prenatal mood and anxiety disorders and associated cytokine changes

Association between inflammatory biomarkers before pregnancy and risk of perinatal depression: A prospective cohort study of 4483 women in Sweden